TY - CHAP AU - Zhan, P. AU - Chen, X. AU - Li, D. AU - Fang, Z. AU - De Clercq, E. AU - Liu, X. PY - 2011 DA - 2011// TI - HIV-1 NNRTIs: Structural diversity, pharmacophore similarity, and implications for drug design BT - Med Res Rev ID - Zhan2011 ER - TY - JOUR AU - Schreiber, S. L. PY - 2000 DA - 2000// TI - Target-oriented and diversity-oriented organic synthesis in drug discovery JO - Science VL - 287 UR - https://doi.org/10.1126/science.287.5460.1964 DO - 10.1126/science.287.5460.1964 ID - Schreiber2000 ER - TY - JOUR AU - Domling, A. AU - Ugi, I. I. PY - 2000 DA - 2000// TI - Multicomponent reactions with isocyanides JO - Angew Chem Int Ed Engl VL - 39 UR - https://doi.org/3.0.CO;2-U DO - 3.0.CO;2-U ID - Domling2000 ER - TY - JOUR AU - Dolle, R. E. PY - 2005 DA - 2005// TI - Comprehensive survey of combinatorial library synthesis: 2004 JO - J Comb Chem VL - 7 UR - https://doi.org/10.1021/cc050082t DO - 10.1021/cc050082t ID - Dolle2005 ER - TY - JOUR AU - Lipinski, C. A. AU - Lombardo, F. AU - Dominy, B. W. AU - Feeney, P. J. PY - 2001 DA - 2001// TI - Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings JO - Adv Drug Deliv Rev VL - 46 UR - https://doi.org/10.1016/S0169-409X(00)00129-0 DO - 10.1016/S0169-409X(00)00129-0 ID - Lipinski2001 ER - TY - JOUR AU - Yasri, A. AU - Berthelot, D. AU - Gijsen, H. AU - Thielemans, T. AU - Marichal, P. AU - Engels, M. AU - Hoflack, J. PY - 2004 DA - 2004// TI - REALISIS: a medicinal chemistry-oriented reagent selection, library design, and profiling platform JO - J Chem Inf Comput Sci VL - 44 UR - https://doi.org/10.1021/ci049879i DO - 10.1021/ci049879i ID - Yasri2004 ER - TY - JOUR AU - Burke, M. D. AU - Schreiber, S. L. PY - 2004 DA - 2004// TI - A planning strategy for diversity-oriented synthesis JO - Angew Chem Int Ed Engl VL - 43 UR - https://doi.org/10.1002/anie.200300626 DO - 10.1002/anie.200300626 ID - Burke2004 ER - TY - JOUR AU - Connor, R. I. AU - Chen, B. K. AU - Choe, S. AU - Landau, N. R. PY - 1995 DA - 1995// TI - Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes JO - Virology VL - 206 UR - https://doi.org/10.1006/viro.1995.1016 DO - 10.1006/viro.1995.1016 ID - Connor1995 ER - TY - JOUR AU - Groebke, K. AU - Weber, L. AU - Mehlin, F. PY - 1998 DA - 1998// TI - Synthesis of imidazo[1,2-a] annulated pyridines, pyrazines and pyrimidines by a novel three-component condensation JO - Synlett VL - 6 UR - https://doi.org/10.1055/s-1998-1721 DO - 10.1055/s-1998-1721 ID - Groebke1998 ER - TY - JOUR AU - Yamashita, M. AU - Emerman, M. PY - 2004 DA - 2004// TI - Capsid is a dominant determinant of retrovirus infectivity in nondividing cells JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.11.5670-5678.2004 DO - 10.1128/JVI.78.11.5670-5678.2004 ID - Yamashita2004 ER - TY - JOUR AU - Konig, R. AU - Zhou, Y. AU - Elleder, D. AU - Diamond, T. L. AU - Bonamy, G. M. AU - Irelan, J. T. AU - Chiang, C. Y. AU - Tu, B. P. AU - De Jesus, P. D. AU - Lilley, C. E. PY - 2008 DA - 2008// TI - Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication JO - Cell VL - 135 UR - https://doi.org/10.1016/j.cell.2008.07.032 DO - 10.1016/j.cell.2008.07.032 ID - Konig2008 ER - TY - JOUR AU - De Clercq, E. PY - 1998 DA - 1998// TI - The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection JO - Antiviral Res VL - 38 UR - https://doi.org/10.1016/S0166-3542(98)00025-4 DO - 10.1016/S0166-3542(98)00025-4 ID - De Clercq1998 ER - TY - JOUR AU - Carroll, S. S. AU - Stahlhut, M. AU - Geib, J. AU - Olsen, D. B. PY - 1994 DA - 1994// TI - Inhibition of HIV-1 reverse transcriptase by a quinazolinone and comparison with inhibition by pyridinones. Differences in the rates of inhibitor binding and in synergistic inhibition with nucleoside analogs JO - J Biol Chem VL - 269 ID - Carroll1994 ER - TY - JOUR AU - King, R. W. AU - Klabe, R. M. AU - Reid, C. D. AU - Erickson-Viitanen, S. K. PY - 2002 DA - 2002// TI - Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.6.1640-1646.2002 DO - 10.1128/AAC.46.6.1640-1646.2002 ID - King2002 ER - TY - JOUR AU - Morningstar, M. L. AU - Roth, T. AU - Farnsworth, D. W. AU - Smith, M. K. AU - Watson, K. AU - Buckheit, R. W. AU - Das, K. AU - Zhang, W. AU - Arnold, E. AU - Julias, J. G. PY - 2007 DA - 2007// TI - Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme JO - J Med Chem VL - 50 UR - https://doi.org/10.1021/jm060103d DO - 10.1021/jm060103d ID - Morningstar2007 ER - TY - JOUR AU - Schindler, M. AU - Munch, J. AU - Kirchhoff, F. PY - 2005 DA - 2005// TI - Human immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanism JO - J Virol VL - 79 UR - https://doi.org/10.1128/JVI.79.9.5489-5498.2005 DO - 10.1128/JVI.79.9.5489-5498.2005 ID - Schindler2005 ER - TY - JOUR AU - Julias, J. G. AU - Boyer, P. L. AU - McWilliams, M. J. AU - Alvord, W. G. AU - Hughes, S. H. PY - 2004 DA - 2004// TI - Mutations at position 184 of human immunodeficiency virus type-1 reverse transcriptase affect virus titer and viral DNA synthesis JO - Virology VL - 322 UR - https://doi.org/10.1016/j.virol.2004.01.004 DO - 10.1016/j.virol.2004.01.004 ID - Julias2004 ER - TY - JOUR AU - Gervaix, A. AU - West, D. AU - Leoni, L. M. AU - Richman, D. D. AU - Wong-Staal, F. AU - Corbeil, J. PY - 1997 DA - 1997// TI - A new reporter cell line to monitor HIV infection and drug susceptibility in vitro JO - Proc Natl Acad Sci USA VL - 94 UR - https://doi.org/10.1073/pnas.94.9.4653 DO - 10.1073/pnas.94.9.4653 ID - Gervaix1997 ER - TY - JOUR AU - Telesnitsky, A. AU - Blain, S. AU - Goff, S. P. PY - 1995 DA - 1995// TI - Assays for retroviral reverse transcriptase JO - Methods Enzymol VL - 262 UR - https://doi.org/10.1016/0076-6879(95)62029-X DO - 10.1016/0076-6879(95)62029-X ID - Telesnitsky1995 ER -